Keyword: oncology

News

AbbVie Completes Pharmacyclics Acquisition

28.05.2015 - AbbVie has completed the acquisition of Pharmacyclics, a deal the Chicago-based US drugmaker says enhances its scientific and commercial presence in oncology. As a wholly owned...

News

Novartis Gets Green Light to Buy GSK Cancer Drugs

27.02.2015 - The U.S. Federal Trade Commission has granted Novartis permission to acquire the GlaxoSmithKline (GSK) oncology portfolio - with some strings attached. Canada's competition...

News

Qiagen and Astellas Pharma to Develop Companion Diagnostics

03.11.2014 - Dutch genetic testing specialist Qiagen has signed a master collaboration agreement with Astellas Pharma, a Japanese R&D-driven global pharmaceutical company, to develop and...

News

Crown Bioscience Opens Oncology Center in North Carolina

24.10.2014 - US drug discovery and development service provider Crown Bioscience has opened a new research center at Kannapolis, North Carolina. The new center, which Crown said represents a...

News

Roche's $8 billion InterMune Buy Not a Sign of More Big Deals

19.09.2014 - The decision by Swiss drugmaker Roche in August to buy US biotech company InterMune for $8.3 billion was "exceptional" and not a sign of more ambitious plans for major acquisitions...

News

Mercachem to Acquire Synthon’s API Business

09.09.2014 - Mercachem, a privately owned European contract research organization, plans to acquire Synthon's Prague-based laboratory and pilot scale operations for manufacturing active...

Markets & Companies

Potential In Eastern Europe

29.07.2014 - Over the past five years, emerging markets have experienced some of the highest pharmaceutical market growth rates, a trend that is expected to continue. Central Eastern Europe...

News

GSK Invites Private Equity Bids for Older Drugs

01.06.2014 - UK pharmaceutical producer GlaxoSmithKline has invited private equity firms to consider making offers for a range of its older drugs, news agencies report, citing people familiar...